Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 112.5K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Silvia de Sanjosé, Wim Quint, Laia Alemany et al. · The Lancet Oncology · 2010 · 2.7K citations

Medicine, Genetics, Oncology +16

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

Elmar A. Joura, Anna R. Giuliano, Ole‐Erik Iversen et al. · New England Journal of Medicine · 2015 · 1.4K citations · Full text

Medicine, Oncology, Preventive Medicine +16

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

Suzanne M. Garland, Marc Steben, Heather L. Sings et al. · The Journal of Infectious Diseases · 2009 · 531 citations · Full text

Medicine, Gynecology, Infectious Diseases +17

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

Warner K. Huh, Elmar A. Joura, Anna R. Giuliano et al. · The Lancet · 2017 · 459 citations · Full text

Veterinary Medicine, Immunology, Oncology +16